Amphastar Pharmaceuticals, Inc. (AMPH) financial statements (2020 and earlier)

Company profile

Business Address 11570 SIXTH STREET
RANCHO CUCAMONGA, CA 91730
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments858968736668
Cash and cash equivalents748666726668
Short-term investments12331  
Restricted cash and investments444111
Receivables455236273323
Inventory, net of allowances, customer advances and progress billings1116964807182
Inventory1116964807182
Deferred tax assets    20
Other undisclosed current assets10616354
Total current assets:255220188184176198
Noncurrent Assets
Finance lease, right-of-use asset1
Operating lease, right-of-use asset19
Property, plant and equipment234210185153142138
Intangible assets, net (including goodwill), including:414245504043
Goodwill444444
Intangible assets, net (excluding goodwill)891117738
Other undisclosed intangible assets, net (including goodwill)29292929290
Deferred income tax assets26
Other noncurrent assets11109954
Deferred tax assets, net31283127 
Other undisclosed noncurrent assets     7
Total noncurrent assets:332293267244214191
TOTAL ASSETS:587514455428390389
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities778758534738
Accounts payable253117161410
Accrued liabilities525641161713
Employee-related liabilities   141311
Taxes payable   833
Debt81865118
Deferred revenue and credits  114
Deferred tax liabilities    1
Other undisclosed current liabilities513222
Total current liabilities:9010767616063
Noncurrent Liabilities
Long-term debt and lease obligation, including:393241323036
Long-term debt, excluding current maturities464946364043
Operating lease, liability16
Other undisclosed long-term debt and lease obligation(23)(17)(5)(4)(10)(7)
Liabilities, other than long-term debt14109448
Deferred revenue and credits 012
Accounts payable and accrued liabilities301100
Deferred tax liabilities, net111 6
Deferred income tax liabilities1
Other liabilities99722 
Other undisclosed noncurrent liabilities16  110
Total noncurrent liabilities:694250383545
Total liabilities:1591491179895108
Stockholders' equity
Stockholders' equity attributable to parent381332337329296282
Common stock000000
Treasury stock, value(98)(75)(51)(20)(10)(0)
Additional paid in capital367344314283248221
Accumulated other comprehensive loss(5)(4)(2)(5)(2)(2)
Retained earnings1166776716063
Stockholders' equity attributable to noncontrolling interest4632    
Total stockholders' equity:428364337329296282
TOTAL LIABILITIES AND EQUITY:587514455428390389

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues322295240255252210
Revenue, net240255252210
Cost of revenue(190)(188)(149)(151)(174)(159)
Gross profit:132107911047751
Operating expenses(132)(116)(92)(88)(84)(69)
Operating income (loss):(0)(9)(1)16(7)(18)
Nonoperating income (expense)60(1)3(1)(3)(0)
Investment income, nonoperating100000
Other nonoperating income (expense)59(2)30(3)0
Interest and debt expense(0)(0)(1)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes     1
Income (loss) from continuing operations before equity method investments, income taxes:60(10)114(11)(18)
Other undisclosed income from continuing operations before income taxes00111 
Income (loss) from continuing operations before income taxes:60(10)215(10)(18)
Income tax expense (benefit)(14)33(4)87
Net income (loss):47(7)511(3)(11)
Net income attributable to noncontrolling interest21    
Net income (loss) available to common stockholders, diluted:49(6)511(3)(11)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):47(7)511(3)(11)
Other comprehensive loss     (2)
Comprehensive income (loss):47(7)511(3)(12)
Comprehensive income, net of tax, attributable to noncontrolling interest21    
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1)(2)3(2)(1) 
Comprehensive income (loss), net of tax, attributable to parent:48(8)78(4)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: